US Patent Issued to SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT on Sept. 16 for "2'-isopropyl-spiro (3,3'-pyrrolidine oxindole) liver X receptor regulator, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,810, issued on Sept. 16, was assigned to SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT Co. LTD. (Guangdong, China).

"2'-isopropyl-spiro (3,3'-pyrrolidine oxindole) liver X receptor regulator, preparation method therefor, and use thereof" was invented by Ziyang Chen (Guangdong, China), Qiong Gu (Guangdong, China), Hao Chen (Guangdong, China) and Jun Xu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a liver X receptor regulator of spiro(3,3'-isopropylpyrrolidine oxindole), as well as a preparation method and use thereof. Specifically, a compound is provided, which is a compound represented by Formula (I); or a stereoi...